Skip to main content
Clinical Trials/NL-OMON56910
NL-OMON56910
Not yet recruiting
Not Applicable

Characterizing the Tumor Immune Microenvironment of Head and Neck Squamous Cell Carcinoma - HNcol 2.0

Amsterdam UMC0 sites1,600 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
head and neck cancer
Sponsor
Amsterdam UMC
Enrollment
1600
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational invasive

Investigators

Sponsor
Amsterdam UMC

Eligibility Criteria

Inclusion Criteria

  • 1\. Patients are scheduled for panendoscopy or surgery for squamous cell
  • carcinoma of the oral cavity, oropharynx, hypopharynx, larynx or cervical part
  • of oesophagus.
  • 2\. Patients must have sufficient knowledge of the Dutch language to understand
  • the meaning of the study as described in the patient information.
  • 3\. Patients must have the mental capacity to understand the meaning of the
  • study as described in the patient information.
  • 4\. Patients must give written informed consent.
  • 5\. Age of the patients should be \>18\. An upper limit of age will not be
  • applied. Elderly patients who are fit enough to undergo surgery in the head and

Exclusion Criteria

  • Too limited size of the carcinoma according to the treating physician.

Outcomes

Primary Outcomes

Not specified

Similar Trials